Literature DB >> 28177318

Crystallization and X-ray analysis of D-threonine aldolase from Chlamydomonas reinhardtii.

Yuki Hirato1, Masaru Goto2, Mayumi Tokuhisa1, Minoru Tanigawa1, Katsushi Nishimura1.   

Abstract

D-Threonine aldolase from the green alga Chlamydomonas reinhardtii (CrDTA) catalyzes the interconversion of several β-hydroxy-D-amino acids (e.g. D-threonine) and glycine plus the corresponding aldehydes. Recombinant CrDTA was overexpressed in Escherichia coli and purified to homogeneity; it was subsequently crystallized using the hanging-drop vapour-diffusion method at 295 K. Data were collected and processed at 1.85 Å resolution. Analysis of the diffraction pattern showed that the crystal belonged to space group P1, with unit-cell parameters a = 64.79, b = 74.10, c = 89.94 Å, α = 77.07, β = 69.34, γ = 71.93°. The asymmetric unit contained four molecules of CrDTA. The Matthews coefficient was calculated to be 2.12 Å3 Da-1 and the solvent content was 41.9%.

Entities:  

Keywords:  Chlamydomonas reinhardtii; crystallization; d-amino acids; d-threonine aldolase

Mesh:

Substances:

Year:  2017        PMID: 28177318      PMCID: PMC5297928          DOI: 10.1107/S2053230X1602063X

Source DB:  PubMed          Journal:  Acta Crystallogr F Struct Biol Commun        ISSN: 2053-230X            Impact factor:   1.056


  14 in total

1.  Gene cloning and overproduction of low-specificity D-threonine aldolase from Alcaligenes xylosoxidans and its application for production of a key intermediate for parkinsonism drug.

Authors:  J Q Liu; M Odani; T Yasuoka; T Dairi; N Itoh; M Kataoka; S Shimizu; H Yamada
Journal:  Appl Microbiol Biotechnol       Date:  2000-07       Impact factor: 4.813

2.  Molecular replacement with MOLREP.

Authors:  Alexei Vagin; Alexei Teplyakov
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-12-21

3.  XDS.

Authors:  Wolfgang Kabsch
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-01-22

Review 4.  Enzymes useful for chiral compound synthesis: structural biology, directed evolution, and protein engineering for industrial use.

Authors:  Michihiko Kataoka; Takuya Miyakawa; Sakayu Shimizu; Masaru Tanokura
Journal:  Appl Microbiol Biotechnol       Date:  2016-05-17       Impact factor: 4.813

5.  A new route to L-threo-3-[4-(methylthio)phenylserine], a key intermediate for the synthesis of antibiotics: recombinant low-specificity D-threonine aldolase-catalyzed stereospecific resolution.

Authors:  J Q Liu; M Odani; T Dairi; N Itoh; S Shimizu; H Yamada
Journal:  Appl Microbiol Biotechnol       Date:  1999-05       Impact factor: 4.813

Review 6.  Threonine aldolases-screening, properties and applications in the synthesis of non-proteinogenic beta-hydroxy-alpha-amino acids.

Authors:  Nina Dückers; Katrin Baer; Sabine Simon; Harald Gröger; Werner Hummel
Journal:  Appl Microbiol Biotechnol       Date:  2010-08-04       Impact factor: 4.813

Review 7.  Scaling and assessment of data quality.

Authors:  Philip Evans
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2005-12-14

8.  Overview of the CCP4 suite and current developments.

Authors:  Martyn D Winn; Charles C Ballard; Kevin D Cowtan; Eleanor J Dodson; Paul Emsley; Phil R Evans; Ronan M Keegan; Eugene B Krissinel; Andrew G W Leslie; Airlie McCoy; Stuart J McNicholas; Garib N Murshudov; Navraj S Pannu; Elizabeth A Potterton; Harold R Powell; Randy J Read; Alexei Vagin; Keith S Wilson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-03-18

9.  The crystal structure of D-threonine aldolase from Alcaligenes xylosoxidans provides insight into a metal ion assisted PLP-dependent mechanism.

Authors:  Michael K Uhl; Gustav Oberdorfer; Georg Steinkellner; Lina Riegler-Berket; Daniel Mink; Friso van Assema; Martin Schürmann; Karl Gruber
Journal:  PLoS One       Date:  2015-04-17       Impact factor: 3.240

Review 10.  Threonine aldolases: perspectives in engineering and screening the enzymes with enhanced substrate and stereo specificities.

Authors:  Kateryna Fesko
Journal:  Appl Microbiol Biotechnol       Date:  2016-01-26       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.